Impact of in utero environment on the offspring of lupus patients

Angela Tincani, E. Danieli, M. Nuzzo, M. Scarsi, M. Motta, R. Cimaz, A. Lojacono, R. Nacinovich, F. Taddei, A. Doria, A. Brucato, P. Meroni

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The number of patients affected by systemic lupus erythematosus (SLE) that decide to have children has greatly increased probably because of recent improvements in the diagnosis and management of the disease. This has stimulated our interest in defining the outcome of children, focusing both on neonatal problems and long term development. SLE patients still carry a risk of pregnancy loss. However, due to careful monitoring and treatment by a multidisciplinary team, the number of losses has dramatically decreased, but an increased number of preterm deliveries is still a problem. Neonatal lupus is linked to the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in the mother, although other factors probably of fetal origin are important. Neonatal lupus is a complex condition whose most serious manifestation is the congenital heart block (CHB). Usually, children with complete CHB need permanent pacing, but apparently do not have neuropsychological problems. Studies focusing on the neuropsychological development of SLE offspring show an increased number of learning disabilities in children with normal intelligence levels. Fetal consequence of maternal treatment need to be considered choosing non teratogenic drugs, but the withdrawal of medications just because the patient is pregnant should be avoided to avoid SLE flares.

Original languageEnglish
Pages (from-to)801-807
Number of pages7
JournalLupus
Volume15
Issue number11
DOIs
Publication statusPublished - 2006

Fingerprint

Systemic Lupus Erythematosus
Mothers
Learning Disorders
Disease Management
Intelligence
Pregnancy
Therapeutics
Pharmaceutical Preparations
Congenital heart block
Neonatal Systemic lupus erythematosus

Keywords

  • Antiphospholipid antibodies
  • Immunosuppressive drugs
  • Learning disabilities
  • Neonatal lupus
  • SLE pregnancy

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Tincani, A., Danieli, E., Nuzzo, M., Scarsi, M., Motta, M., Cimaz, R., ... Meroni, P. (2006). Impact of in utero environment on the offspring of lupus patients. Lupus, 15(11), 801-807. https://doi.org/10.1177/0961203306071005

Impact of in utero environment on the offspring of lupus patients. / Tincani, Angela; Danieli, E.; Nuzzo, M.; Scarsi, M.; Motta, M.; Cimaz, R.; Lojacono, A.; Nacinovich, R.; Taddei, F.; Doria, A.; Brucato, A.; Meroni, P.

In: Lupus, Vol. 15, No. 11, 2006, p. 801-807.

Research output: Contribution to journalArticle

Tincani, A, Danieli, E, Nuzzo, M, Scarsi, M, Motta, M, Cimaz, R, Lojacono, A, Nacinovich, R, Taddei, F, Doria, A, Brucato, A & Meroni, P 2006, 'Impact of in utero environment on the offspring of lupus patients', Lupus, vol. 15, no. 11, pp. 801-807. https://doi.org/10.1177/0961203306071005
Tincani A, Danieli E, Nuzzo M, Scarsi M, Motta M, Cimaz R et al. Impact of in utero environment on the offspring of lupus patients. Lupus. 2006;15(11):801-807. https://doi.org/10.1177/0961203306071005
Tincani, Angela ; Danieli, E. ; Nuzzo, M. ; Scarsi, M. ; Motta, M. ; Cimaz, R. ; Lojacono, A. ; Nacinovich, R. ; Taddei, F. ; Doria, A. ; Brucato, A. ; Meroni, P. / Impact of in utero environment on the offspring of lupus patients. In: Lupus. 2006 ; Vol. 15, No. 11. pp. 801-807.
@article{2406777e0ff646b49749c649169662e4,
title = "Impact of in utero environment on the offspring of lupus patients",
abstract = "The number of patients affected by systemic lupus erythematosus (SLE) that decide to have children has greatly increased probably because of recent improvements in the diagnosis and management of the disease. This has stimulated our interest in defining the outcome of children, focusing both on neonatal problems and long term development. SLE patients still carry a risk of pregnancy loss. However, due to careful monitoring and treatment by a multidisciplinary team, the number of losses has dramatically decreased, but an increased number of preterm deliveries is still a problem. Neonatal lupus is linked to the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in the mother, although other factors probably of fetal origin are important. Neonatal lupus is a complex condition whose most serious manifestation is the congenital heart block (CHB). Usually, children with complete CHB need permanent pacing, but apparently do not have neuropsychological problems. Studies focusing on the neuropsychological development of SLE offspring show an increased number of learning disabilities in children with normal intelligence levels. Fetal consequence of maternal treatment need to be considered choosing non teratogenic drugs, but the withdrawal of medications just because the patient is pregnant should be avoided to avoid SLE flares.",
keywords = "Antiphospholipid antibodies, Immunosuppressive drugs, Learning disabilities, Neonatal lupus, SLE pregnancy",
author = "Angela Tincani and E. Danieli and M. Nuzzo and M. Scarsi and M. Motta and R. Cimaz and A. Lojacono and R. Nacinovich and F. Taddei and A. Doria and A. Brucato and P. Meroni",
year = "2006",
doi = "10.1177/0961203306071005",
language = "English",
volume = "15",
pages = "801--807",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Impact of in utero environment on the offspring of lupus patients

AU - Tincani, Angela

AU - Danieli, E.

AU - Nuzzo, M.

AU - Scarsi, M.

AU - Motta, M.

AU - Cimaz, R.

AU - Lojacono, A.

AU - Nacinovich, R.

AU - Taddei, F.

AU - Doria, A.

AU - Brucato, A.

AU - Meroni, P.

PY - 2006

Y1 - 2006

N2 - The number of patients affected by systemic lupus erythematosus (SLE) that decide to have children has greatly increased probably because of recent improvements in the diagnosis and management of the disease. This has stimulated our interest in defining the outcome of children, focusing both on neonatal problems and long term development. SLE patients still carry a risk of pregnancy loss. However, due to careful monitoring and treatment by a multidisciplinary team, the number of losses has dramatically decreased, but an increased number of preterm deliveries is still a problem. Neonatal lupus is linked to the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in the mother, although other factors probably of fetal origin are important. Neonatal lupus is a complex condition whose most serious manifestation is the congenital heart block (CHB). Usually, children with complete CHB need permanent pacing, but apparently do not have neuropsychological problems. Studies focusing on the neuropsychological development of SLE offspring show an increased number of learning disabilities in children with normal intelligence levels. Fetal consequence of maternal treatment need to be considered choosing non teratogenic drugs, but the withdrawal of medications just because the patient is pregnant should be avoided to avoid SLE flares.

AB - The number of patients affected by systemic lupus erythematosus (SLE) that decide to have children has greatly increased probably because of recent improvements in the diagnosis and management of the disease. This has stimulated our interest in defining the outcome of children, focusing both on neonatal problems and long term development. SLE patients still carry a risk of pregnancy loss. However, due to careful monitoring and treatment by a multidisciplinary team, the number of losses has dramatically decreased, but an increased number of preterm deliveries is still a problem. Neonatal lupus is linked to the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in the mother, although other factors probably of fetal origin are important. Neonatal lupus is a complex condition whose most serious manifestation is the congenital heart block (CHB). Usually, children with complete CHB need permanent pacing, but apparently do not have neuropsychological problems. Studies focusing on the neuropsychological development of SLE offspring show an increased number of learning disabilities in children with normal intelligence levels. Fetal consequence of maternal treatment need to be considered choosing non teratogenic drugs, but the withdrawal of medications just because the patient is pregnant should be avoided to avoid SLE flares.

KW - Antiphospholipid antibodies

KW - Immunosuppressive drugs

KW - Learning disabilities

KW - Neonatal lupus

KW - SLE pregnancy

UR - http://www.scopus.com/inward/record.url?scp=39049085665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049085665&partnerID=8YFLogxK

U2 - 10.1177/0961203306071005

DO - 10.1177/0961203306071005

M3 - Article

C2 - 17153854

AN - SCOPUS:39049085665

VL - 15

SP - 801

EP - 807

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 11

ER -